BIOMEDICINE:
The NASA-NCI Collaboration on Biomolecular Sensors
Daniel S. Goldin, Carol A. Dahl,* Kathie L. Olsen, Louis H. Ostrach,* Richard D. Klausner
NASA and the NCI are launching a joint program to support the development of radically new technologies for biomolecular sensors. The collaboration of these disparate agencies results from their recognition of common needs for minimally invasive strategies for early detection, diagnosis, and treatment of disease and radiation damage. The biomolecular sensors sought by the agencies will build on new discoveries in nanoscale sensing of macromolecules and tools to enable dynamic monitoring that will be developed through the new joint program. NASA and NCI invite the participation of scientists, technologists, and engineers from all disciplines in meeting the challenges set forward in the new program.
D. S. Goldin is administrator of the National Aeronautics and Space Administration (NASA), Washington, DC 20546, USA. C. A. Dahl is director of the Office of Technology and Industrial Relations, National Cancer Institute (NCI), Bethesda, MD 20892, USA. K. L. Olsen is NASA chief scientist and acting associate administrator for the Office of Biological and Physical Research. L. H. Ostrach is flight experiment integration executive, Office of Biological and Physical Research, NASA, Washington, DC 20546, USA. R. D. Klausner is director of the NCI, Bethesda, MD 20892, USA.
*To whom correspondence should be addressed. E-mail: lostrach{at}hq.nasa.gov and carol_dahl{at}nih.giv
